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progenies due to their stem cell tumor
phenotype, the gonads may contain a
larger pool of bam/bgcn germline cells
that dedifferentiate to regain a stem cell
identity (Figure 1B). However, in either
case, abundance of E-cadherin appears
to be very important for GSC competition,
because merely increasing E-cadherin
levels makes GSCs more competitive
than those with lower E-cadherin levels.
Yet again, it is also possible that germ
cells with higher E-cadherin levels are
more competitive during dedifferentia-
tion/reversion (Figure 1C). Only live imag-
ing will allow us to distinguish between the
‘‘forcing out’’ model and the ‘‘competitive
dedifferentiation’’ model. Whatever the
case, it is clear that stem cells and ‘‘po-
tential stem cell populations’’ (which can
revert back to a more primitive state)
have a competitive relationship, resulting
in one dominant population.
The niche hypothesis was first pro-
posed based on the observation that
host stem cells have to be depleted to
allow efficient hematopoietic stem cell
(HSC) engraftment during bone marrow
transplantation. Almost 30 years of work
has added support to this model, most
recently by Czechowicz and colleagues
(Czechowicz et al., 2007). This elegant
study demonstrated that removal of host
HSCs by treatment with a c-Kit-blocking
antibody led to a dramatic increase in
donor cell engraftment. The hematopoi-
etic system, therefore, also appears to ex-
hibit stem cell competition for access to
limited niches, at least during situations
of HSC transplantation. Jin et al. (2008)
propose that stem cell competitiveness
might play a role in the quality control of
stem cells, excluding those with a low ca-
pacity for interaction with niche-support-
ing cells. It is also possible that a subset
of mutant cells within the tissue may ac-
quire a higher capacity for niche interac-
tion (through upregulation of adhesion
molecules, for example), allowing them
to outcompete genuine stem cells and
home into the niche for more ‘‘stem cell
inducing signals,’’ possibly leading to tu-
morigenesis (for review, see Sneddon
and Werb, 2007). Of note, virtually all leu-
kemic/lymphoma cells have a clonal ori-
gin (Warner et al., 2004), suggesting that
tumorigenic cells, or cancer stem cells,
may have higher capacity to interact
with the niche and therefore outcompete
normal stem cells to finally conquer all
available stem cell niches. Thus, it would
be interesting to determine whether can-
cer stem cells reside in the normal stem
cell niche, although it is also possible
that they are freed from niche depen-
dence for their proliferation. It is tempting
to speculate that such stem cell competi-
tion play a role in the transition from a be-
nign tumor to a malignant tumor. These
possibilities await further testing. For the
moment, Jin et al. have uncovered a new
feature of stem cells. Namely, they do
not share their residence in peace, but
seek to occupy the niche alone.
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Nanog is a transcription factor that is expressed by mouse and human embryonic stem (ES) cells and
by primordial germ cells. New research published recently in Nature (Chambers et al., 2007) points to an
unexpected role for Nanog in the maintenance of pluripotency in mouse ES cells.ES cells combine the capacity for indefi-
nite growth in an undifferentiated state
with the ability to differentiate into all tis-
sues of an adult mouse. When they were
first derived by explanting early mouse4 Cell Stem Cell 2, January 2008 ª2008 Elseembryos into culture, success depended
crucially upon the use of inactivated
fibroblasts as feeder cells. However, the
nature of the molecular machinery that
maintained the two key features of ESvier Inc.cells, their capacity for self renewal and
pluripotency, and the role of the feeder
cells were obscure.
The first clue came from studies that
showed that a single growth factor,
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Previewsleukaemia inhibitory factor (LIF), was able
to replace the need for the feeder cells
and allow culture of mouse ES cells indef-
initely without the use of feeders (Smith
et al., 1988). Building on this discovery,
further work revealed that LIF appeared
to act by balancing two signaling
cascades within ES cells, one through
STAT3 that promoted self-renewal and
one through the ERK pathway that ap-
peared to promote differentiation.
Next came thediscovery that the precise
level of a transcription factor,Oct4,which is
normally downregulated upon ES cell dif-
ferentiation, is crucial for the maintenance
of the undifferentiated state. If the levels of
Oct4were forcibly reduced by genetic ma-
nipulation, differentiation to trophectoderm
occurred,whereas if the levelswere raised,
differentiation to endoderm is promoted
(Niwa et al., 2000). However, both LIF and
the correct levels of Oct4 were required to
maintain the undifferentiated state.
Other genes also showed marked de-
velopmental regulation in ES cells, and
the question arose as to whether any of
these might act upstream of Oct4 or LIF
to maintain a pluripotent state. One of
these, Nanog, initially appeared to be the
key gene required to maintain the pluripo-
tent state (Mitsui et al., 2003; Chambers
et al., 2003). Overexpression of Nanog
prevented differentiation of ES cells and
allowed their maintenance in the absence
of LIF. However, continued expression of
Oct4was also necessary for maintenance
of an undifferentiated stem cell state. A
model of pluripotency emerged in which
Oct4 and Nanog appeared to act at the
same level to both promote self-renewal
and suppress differentiation. ChIP-on-
chip studies further revealed a close rela-
tionship between Oct4 and Nanog and
another pluripotency-associated factor,
Sox2, all of which appear to interact in
feedback regulatory circuits (Boyer et al.,
2005). Together with other reports, these
observations pointed to Nanog, Oct4,
and Sox2 acting together as master reg-
ulators of pluripotency. Nevertheless,
when Takahashi and Yamanaka (2006)
recently described that four genes, Oct4,
Sox2, Klf4, and c-Myc, were sufficient to
reprogram adult somatic cells to an ES
cell-like state, so-called induced pluripo-
tent stem (iPS) cells, Nanog was not
among them.
New results reported in Nature (Cham-
bers et al., 2007) provide some new andsurprising insights into the role of Nanog,
and perhaps into the nature of the stem
cell state itself. Because earlier studies
had indicated that some Oct4(+) cells did
not appear to express Nanog, the authors
inserted the fluorescent reporter protein
eGFP into the Nanog locus of mouse ES
cells by homologous recombination. Sub-
sets of eGFP(+) [Nanog(+)] and eGFP()
[Nanog()] cells were found in these trans-
genic ES cultures, but both expressed
other ES markers, SSEA1 and Oct4. Im-
portantly, after isolation by FACS, the
eGFP() [Nanog()] cells gave rise to
eGFP(+) [Nanog(+)] cells; the undifferenti-
ated stem cells appeared to oscillate be-
tween a Nanog(+) and a Nanog() state.
In further experiments, the authors derived
Nanog null ES cells and showed that these
could proliferate as pluripotent stem cells.
Thus, they found that expression of Nanog
is not essential for maintenance of the un-
differentiated stem cell state. In their mo-
del, the Nanog() cells appear to be more
susceptible to differentiation, whereas the
expression of Nanog appears to suppress
differentiation. In addition, Nanog is nor-
mally expressed in primordial germ cells.
In contrast with its expendable function in
ES cells, however, these cells do not ap-
pear to survive in the absence of Nanog.
The authors suggest that the common fea-
turemight bea roleofNanog inmaintaining
survival of cells in an epigenetic plastic
state. Putting all this together, Nanog ap-
pears to be acting in a modulator capacity
rather than as a ‘‘core’’ pluripotency deter-
minant.
The apparent separation of undifferenti-
ated ES cells into two interchangeable
states reflects studies of other stem cell
systems in which it is becoming apparent
that the stem cell compartmentmay be of-
ten heterogeneous, with the cells capable
of adopting various interchangeable sub-
states. For example, within the intestinal
crypt, there are suggestions that the stem
cellcompartment isnotcomposedofadis-
crete entity but that cells that under some
circumstances might be termed progeni-
tor cells can under other circumstances
convert back to an apparently true stem
cell-like state (Booth and Potten, 2000).
Likewise substates within the hematopoi-
etic stem cell compartment are becoming
evident (Rosu-Myles et al., 2000).
How does all this relate to human
embryonic stem cells? Recently we de-
scribed substates within the stem cellCell Stemcompartment in human ES cells cultures
(Enver et al., 2005). In this case, the phe-
nomenon of culture adaptation provided
an experimental situation in which we
were able to suggest that human ES cells
can fluctuate between two states that ex-
press, or do not express, the surface anti-
gen SSEA3 yet retain the undifferentiated
state. When human ES cells acquire kar-
yotypic abnormalities and adapt to cul-
ture, the cells seem to be trapped within
the stem cell compartment, which allows
observation of the two SSEA3(+) and
SSEA3() substates. Intriguingly, adapta-
tion of human ES cells often involves the
acquisition of extra copies of chromo-
some 12, on which includes the locus for
Nanog.
The emergence of multiple states within
the stem cell compartment of pluripotent
cells points to more probabilistic rather
than deterministic models of the mainte-
nance and exit from the stem cell state.
The results also emphasize that elucida-
tion of networks of potential interacting
genes by methods such as ChIP on chip
must be backed upwith functional assays.
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